Masitinib is an orally administered tyrosine kinase inhibitor that targets activated cells of the neuroimmune system (mast cells and microglia).
Domain | masitinibinhibitor.com |
---|---|
Homepage URL | https://masitinibinhibitor.com/service-involving-platelets-as-well-as-occurrence-involving-cerebral-vasospasm-along-with-overdue-cerebral-ischemia-subsequent-subarachnoid-lose-blood-in-a-potential-pilot-trial/ |
Keywords | masitinib inhibitor tas1r modulator hardware infection |
Sprache | englisch |